Acer Medical has expanded its artificial intelligence (AI) healthcare presence in Thailand through new collaborations with local partners in healthcare and industry settings.

• Technology deployment: The company’s “VeriSee DR” AI-assisted system is being used to support diabetic retinopathy screening by analysing retinal (fundus) images to assist clinicians in identifying high-risk patients.
• Implementation settings: The collaboration involves deployment across healthcare facilities in Thailand, including use in ophthalmic screening workflows and telemedicine-related services.
• Market development: The initiative follows regulatory approval from the Thailand Food and Drug Administration (TFDA) and forms part of broader efforts to integrate AI diagnostic tools into Thailand’s healthcare system.

This summary is based on a news article issued by BioSpectrum Asia.

Image for illustrative purposes only. Source: Canva.

About Ehub365

For Corporate Clients, ehub365 division delivers critical insights into the ASEAN medical sector, covering investments, new services, and practitioner news. 

A member of 365Asia. Our additional group services are Health365, 365Asia, 健康365, 365Sehat, and 365MEC.